With the symbolic groundbreaking a new chapter has begun for the medical device company OSARTIS GmbH, which is currently still located in Dieburg. After the company had already purchased the 13.000 m2 property in Münster’s development area “Im Seerich” in 2019, the construction work on the new headquarter of OSARTIS GmbH is finally starting now. A modern office building as well as an associated production hall and warehouse are being built. Currently OSARTIS GmbH is planning on starting the relocation from Dieburg to the new headquarter in Münster in spring 2022.
OSARTIS GmbH is a globally active, medium-sized medical device company that sells its products in more than 80 countries around the world. The main markets for OSARTIS GmbH are Europe and North America. At the present time, OSARTIS GmbH employs about 100 staff members. The company was founded in 1994 with only a handful of employees at its headquarter in Lagerstraße Dieburg by former workers of the pharmaceutical group Merck KGaA, at that time with the company name Coripharm Medizinprodukte GmbH. After constant growth and various structural changes OSARTIS GmbH has been part of the Milan-based Demetra Holding since May 2016.
OSARTIS GmbH develops, produces and distributes innovative medical devices for use in orthopedics as well as trauma and spine surgery. The products of OSARTIS GmbH are used exclusively in surgery rooms. These include various bone cements e.g. for anchoring of joint prostheses and for spinal application, instruments for implantation of such bone cements as well as synthetic bone substitutes, made of chemically body-like starting materials.
Innovation and growth are important topics for OSARTIS GmbH. That is why in the company’s own development department about a dozen of specialized engineers, scientists and technicians are working on the development of new products for a better patient care; a process that in many cases takes more than five years due to the high legal requirements.
After more than 20 successful years in the business premises in Lagerstraße 11-15 it is not easy for anyone to leave Dieburg. But the existing facilities are too small and do not allow the expansion of the company. Therefore OSARTIS GmbH had to search for a new suitable location in the close proximity, which was found in the development area “Im Seerich” in Münster.
OSARTIS GmbH is a German medical device company focused on the development, registration, production and sales of medical biomaterials and PMMA bone cements for the orthopaedic, trauma and spinal surgery.
The constant growth of OSARTIS GmbH requires a spatial expansion and an essential step to enlarge our company. For this reason, OSARTIS GmbH has acquired a property in Münster (Hessen). The ground-breaking ceremony for the construction of a new building is scheduled for summer 2020, the relocation for 2021.
To start this process, the business address was changed as of May 28, 2020 in the first step. The new business address is:
Auf der Beune 101
64839 Münster (Hessen)
Until the completion of the new building in Münster, the employees of OSARTIS GmbH can be contacted and will continue to be located in Lagerstraße 11-15, 64807 Dieburg.
All business relationships will continue unchanged. The bank details, the commercial register and VAT number will also remain unchanged.
OSARTIS GmbH is a medical device company based in Dieburg, Germany.
The company has been focusing on the development, registration, production and sales of medical biomaterials and PMMA bone cements for the fields of orthopaedics, trauma and spinal surgery for more than 20 years. PMMA bone cements for orthopaedics and spinal surgery are mainly developed and manufactured to be marketed to global orthopaedic companies. In addition, own branded products are also distributed to trading partners worldwide. The international distribution is carried out exclusively by trading partners, while in Germany OSARTIS GmbH sells also to hospitals or hospital purchasing groups.
On July 1st, 2018 our former company name aap Biomaterials GmbH was changed to our new company name OSARTIS GmbH by registration in the commercial register Darmstadt.
Background is the new positioning of the company under the roof of the Demetra Holding since May 2016.
For the fields of orthopaedics, trauma and spinal surgery the following products are offered:
* Product launch November 2018
As a new information platform the new website www.osartis.de is available in the OSARTIS corporate design to all customers and all interested parties since July 2nd, 2018. Within the scope of the renaming all marketing tools were altered according to the new corporate design guidelines.
All business relationships will be continued unchanged. The known business address, bank details, commercial register number and VAT number also remain unchanged.
aap Biomaterials GmbH is a medical device company based in Dieburg, Germany. For more than 20 years, the company is focused on the development, registration and production of biomaterials and PMMA bone cements.
Since May 2016, aap Biomaterials GmbH is newly positioned in the Demetra Holding and is operating independently in the fields of indication of orthopaedics, trauma and spinal surgery for its trading partners and customers all over the world. To put an emphasis on this independency and new policy, the change of the company name has been decided, which will be implemented in two steps.
During the first phase in October 2017 we have released the new logo OSARTIS and the new corporate design. Our current website www.osartis.de is accessible for our customers and business partners and all employees of aap Biomaterials GmbH are available under the email addresses @osartis.de.
On July 1st, 2018 the second phase will be started with the official name change of the company into OSARTIS GmbH documented in the German Commercial Register.
aap Biomaterials GmbH is a medical device company based in Dieburg, Germany.
For more than 20 years, the company is focused on the development, registration and production of biomaterials and PMMA bone cements.
Since May 2016, aap Biomaterials GmbH is newly positioned in the Demetra Holding and is operating independently in the fields of indication of orthopaedics, trauma and spinal surgery for its trading partners and customers all over the world.
Since February 2017, aap Biomaterials GmbH is the direct distributor for the products listed below:
To put an emphasis on this independency and new policy, the long-term change of the company name has been decided. In the first step the new logo OSARTIS will be presented for the first time during the German Congress of Orthopaedic and Trauma Surgery in Berlin October 2017. The corporate design will be released with the company presentation in the exhibition area of that congress.
At this date, the new website www.osartis.de will be activated and established as the new information platform for our customers and business partners.
The change of the company name will be implemented in several steps. In the first phase, the name of the company aap Biomaterials GmbH remains the same. With the release of the new website, the previous email addresses of the employees @aapbio.de will be forwarded for some time to the new email addresses @osartis.de.